Prevalence and Presentation of Hepatitis B and C Virus (HBV and HCV) Infection in Vietnamese Americans via Serial Community Serologic Testing

Journal of Immigrant and Minority Health

Volumn 17, Issue 1, 2015, Pages 13-20

  Nguyen, Kelvin ^a   Van Nguyen, Thai ^b   Shen, Duke ^a   Xia, Victor ^c   Tran, Diep ^b   Banh, Khanh ^b   Ruan, Victor ^a   Hu, Ke Qin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Vietnamese American Cancer Foundation   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatitis B; Hepatitis C; Orange County; Prevalence; Vietnamese Americans

Indexed keywords

ADOLESCENT; ADULT; AGED; ASIAN AMERICAN; CALIFORNIA; DEMOGRAPHY; ETHNOLOGY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTOR; SEROLOGY; UNITED STATES; VERY ELDERLY; VIET NAM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; CALIFORNIA; DEMOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROLOGIC TESTS; UNITED STATES; VIETNAM;

EID: 84892900344     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-013-9975-5     Document Type: Article

References (52)

1. World Health Organization. Fact sheet: hepatitis B. 2008.
2. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158–68.
3. Weiss RA, McMichael AJ. Social and environmental risk factors in the emergence of infectious diseases. Nat Med. 2004;10:S70–6.
4. Institute of Medicine. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: The National Academies Press; 2010.
5. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group. N Engl J Med. 1997;336:1855–9.
6. CDC website. http://www.cdc.gov/hepatitis/B/bFAQ.htm#statistics. Accessed 29 Sept 2012.
7. Kowdley KV, Wang CC, Welch S, et al. Prevalence of chronic hepatitis B among foreign- born persons living in the United States by country of origin. Hepatology. 2012;56:422–33.
8. Bosch FX, Ribes J, Cleries R, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191–211.
9. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet. 1981;2:1129–33.
10. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B viral infection: relation of age to the clinical expression of disease and subsequent development of carrier state. J Infec Dis. 1985;151:599–603.
11. Beasley RP, Trepo C, Stevens CE, et al. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol. 1977;105:94–8.
12. London WT, McGlynn KA. Liver cancer. In: Scottenfield D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press; 1996. p. 772–93.
13. Johnson PJ. The epidemiology of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 1996;8:845–9.
14. Lok ASF, McMahon BJ. AASLD practice guideline: corrections to AASLD guidelines on chronic hepatitis B. Hepatology. 2007;45:1347.
15. Lok ASF, McMahon BJ. AASLD practice guidelines: hepatitis B. Hepatology. 2007;45:507–39.
16. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology. 2001;34:1225–41.
17. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661–2.
18. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C: 2002. Hepatology. 2002;36:S3–20.
19. Yu ML, Chuang WL. Treatment of chronic hepatitis C in Asia: when East meets West. J Gastroenterol Hepatol. 2009;24:336–45.
20. Statement Consensus. J Viral Hepat. 2004;11:2–4.
21. Pan CQ, Hu K-Q, Ding C, Cheung E. Prevalence of HCV and Risk of HCV acquisition in hepatitis C screening programs in Asian community in New York City. Am J Gastroenterology. 2008;103:S138.
22. Reeves TJ, Bennett CE. The Asian and pacific islander population in the United States. Washington DC: Census Bureau. Current Population Reports; 2003. p. 20–540.
23. U.S. Census Bureau. The American community-Asians: 2004, the American community survey reports. Washington, DC: Department of Commerce; 2007.
24. McPhee SJ, Stewart S, Brock KC, et al. Factors associated with breast and cervical cancer screening practices among Vietnamese American women. Cancer Detect Prev. 1997;21:510–21.
25. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46:1034–40.
26. Goodman RA, Sikes RK. Hepatitis B markers in Southeast Asian refugees. JAMA. 1984;251:2086.
27. Klontz KC. A program to provide hepatitis B immunoprophylaxis to infants born to HBsAg-positive Asian and Pacific Island women. West J Med. 1987;146:195–9.
28. Centers of Disease Control and Prevention. Screening for hepatitis B virus infection among refugees arriving in the United States, 1979–1991. MMWR Morb Mortal Wkly Rep. 1991;40:784–6.
29. Hwang SJ, Tong MJ, Lai PP, et al. Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the Unites States of America. J Gastroenterol Hepatol. 1996;11:949–54.
30. Choe J, Taylor V, Yasui Y, et al. Health care access and sociodemographic factors associated with hepatitis B testing in Vietnamese American men. J Immigr Minor Health. 2006;8:193–201.
31. Johnson PJ. The epidemiology of hepatocellular carcinoma. Eur J Ganstroenterol Hepatol. 1996;8:845–9.
32. Kallman JB, Tran S, Arsalla A, et al. Vietnamese community screening for hepatitis B virus and hepatitis C virus. J Viral Hepat. 2011;18:70–6.
33. Census Bureau Reports. http://www.Census.gov. Accessed 5 Jan 2011.
34. Lee J, Lok A, Chen J. Hepatitis B prevalence among Asian Americans: an assessment to guide future education and intervention strategies. J Community Health. 2010;35:534–42.
35. Philbin M, Erby L, Lee S, et al. Hepatitis B and liver cancer among three Asian American subgroups: A focus group inquiry. J Immigtant Minority Health 2011 (online published).
36. Lee H, Hontz I, Warner A, et al. Hepatitis B infection among Asian American pacific islanders in the rocky mountain area. Appl Nurs Res. 2005;18:2–6.
37. Kato Y, Nakao K, Hamasaki K, et al. Spontaneous loss of hepatitis B surface antigen in chronic carriers, based on a long-term follow-up study in Goto Islands. Japan. J Gastroenterol. 2000;35:201–5.
38. Tsang TK, Blei AT, O’Reilly DJ, et al. Clinical significance of concurrent hepatitis B surface antigen and antibody positivity. Dig Dis Sci. 1986;31:620–4.
39. Shiels MT, Taswell HF, Czaja AJ, et al. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastroenterology. 1987;93:675–80.
40. Hayashi J, Noguchi A, Nakashima K, et al. Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa Japan. Gastroenterol Jpn. 1990;25:593–7.
41. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–62.
42. Nguyen MH, Keeffe EB. Chronic hepatitis B and hepatitis C in Asian Americans (review). Rev Gastroenterol Disord. 2003;3:125–34.
43. Nguyen MH, Whittemore AS, Garcia RT, et al. Role of ethnicity in risk for hepatocellularcarcinoma in patients with chronic hepatitis C and cirrhosis. Clin Gastroenterol Hepatol. 2004;2:820–4.
44. Shepard CW, Simard EP, Finelli L, et al. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112–25.
45. Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features viral interactions, and treatment. J Gastroenterol Hepatol. 2008;23:512–20.
46. Jamma S, Hussain G, Lau DT. Current concepts of HBV/HCV coinfection: coexistence, but not necessarily in harmony. Curr Hepat Rep. 2010;9:260–9.
47. Liaw YF, Tsai SL, Chang JJ, et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology. 1994;106:1048–53.
48. Zarski JP, Bohn B, Bastie A, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol. 1998;28:27–33.
49. Hwang JP, Mohseni M, Gor BJ, et al. Hepatitis B and hepatitis C prevalence and treatment referral among Asian Americans undergoing community-based hepatitis screening. Am J Public Health. 2010;100:S118–24.
50. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR. 2012;61:1–18.
51. Smith BD, Patel N, Beckett GA, et al. Hepatitis C virus antibody prevalence, correlates and predictors among persons born from 1945 through 1965, United States, 1999–2008 (Abstract). American Association for the Study of Liver Disease, November 6, 2011. San Francisco, CA 2011.
52. Shehab TM, Sonnad SS, Lok AS. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat. 2001;8:377–83.